<doc>
  <docmeta id="113s2407is">
    <bill congress="113" type="s" number="2407" version="is"/>
    <revision size="22062" annotations="0" status="complete" id="6" commit-time="2014-06-20T21:54:30Z" committer="mbohmer" doc="113s2407is/6.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
  <metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 S2407 IS: 21st Century Global Health Technology Act</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-05-22</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code>
    <congress>113th CONGRESS</congress>
    <session>2d Session</session>
    <legis-num>S. 2407</legis-num>
    <current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
    <action>
      <action-date date="20140522">May 22, 2014</action-date>
      <action-desc>
        <sponsor name-id="S229">Mrs. Murray</sponsor> introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSFR00">Committee on Foreign Relations</committee-name>
      </action-desc>
    </action>
    <legis-type>A BILL</legis-type>
    <official-title>To amend the Foreign Assistance Act of 1961 by authorizing the United States Agency for
			 International Development to continue supporting the development of
			 technologies for global health under the Health Technologies Program, and
			 for other purposes. </official-title>
  </form>
  <legis-body>
    <section id="S1" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
		  <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="21st Century Global Health Technology Act" proposed="true">21st Century Global Health Technology Act</cato:entity-ref>
          </short-title>
        </quote>.</text>
    </section>
    <section id="id80e84aa643f0430493eaefcf55c54ccb">
      <enum>2.</enum>
      <header>Findings</header>
      <text display-inline="no-display-inline">
        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> makes the following findings:</text>
      <paragraph id="id7ed4bb16ee6f4a4a9d686af8093f0f7b">
        <enum>(1)</enum>
        <text>Research and development is a critical component of United States leadership in global health.</text>
      </paragraph>
      <paragraph id="id7BDF3FE02D8B4E6CB59372284102F7DA">
        <enum>(2)</enum>
        <text>Research and innovation can help to break the cycle of aid dependency by providing sustainable
			 solutions to long-term problems.</text>
      </paragraph>
      <paragraph id="id9713350DAC2E4B8E9EC4AC42DE80CF70">
        <enum>(3)</enum>
        <text>Research and development for global health is crucial for meeting new and emerging challenges,
			 creating efficiencies, strengthening health systems, shifting tasks,
			 strengthening workforces, and increasing access to health services for the
			 most vulnerable people.</text>
      </paragraph>
      <paragraph id="id9B84754708AA4934BA20219823509707">
        <enum>(4)</enum>
        <text>Advances in health and medical technologies have been the major drivers behind massive improvements
			 in health worldwide during the past century, resulting in an average
			 increase in life expectancy of 21 years in low- and middle-income
			 countries between 1960 and 2002.</text>
      </paragraph>
      <paragraph id="idE4AEEE0380534F59B649AACACC09B4DE">
        <enum>(5)</enum>
        <text>New health technologies have a high return on investment. For example, a new meningitis A vaccine
			 developed in collaboration with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">United States Agency for International
			 Development</cato:entity-ref> (referred to in this section as <quote>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>
          </quote>), the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for Disease Control and Prevention</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7529" entity-type="federal-body">National Institutes of Health</cato:entity-ref>, and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food
			 and Drug Administration</cato:entity-ref>, will save an estimated $570,000,000 in costs that
			 would otherwise be incurred for emergency vaccination campaigns during the
			 next decade, freeing much needed resources for use elsewhere in
			 overstretched health systems.</text>
      </paragraph>
      <paragraph id="id141c942cc1294e8596bfc8329eb10e50">
        <enum>(6)</enum>
        <text>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for Disease Control and Prevention</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7529" entity-type="federal-body">National Institutes of Health</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food
			 and Drug Administration</cato:entity-ref>, and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="9700" entity-type="federal-body">Department of Defense</cato:entity-ref> provide significant
			 contributions each year to global health research and development. The
			 United States Government is supporting the development of 200 of the 365
			 products in the global pipeline of products for neglected and
			 poverty-related diseases.</text>
      </paragraph>
      <paragraph id="id3f7c32a81add4a96a5ba7149adca4265">
        <enum>(7)</enum>
        <text>This commitment from the United States Government has led to a remarkable increase in global health
			 products. Forty-five new health tools were registered between 2000 and
			 2010, and the United States Government was involved in 24 of these new
			 global health products in the last decade, including—</text>
        <subparagraph id="idBE060F0F101548769FE6F330E7B91708">
          <enum>(A)</enum>
          <text>6 drugs for malaria;</text>
        </subparagraph>
        <subparagraph id="id07AC928247C245458981DCD2C13793D8">
          <enum>(B)</enum>
          <text>2 vaccines for pneumonia;</text>
        </subparagraph>
        <subparagraph id="idC304C5E69E2940C798DF6EB50B432DBB">
          <enum>(C)</enum>
          <text>6 diagnostics for tuberculosis; and</text>
        </subparagraph>
        <subparagraph id="id664E46B572784E5C9228020FD7FB554C">
          <enum>(D)</enum>
          <text>2 drugs for leishmaniasis.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="idcff2f209facc4dbca2f5b4235923d3ce">
        <enum>(8)</enum>
        <text>Although investments from the United States Government have enabled tremendous progress in the
			 introduction of new technologies for global health, gaps still exist in
			 bringing certain technologies through the development process and rapidly
			 scaling them up in the field.</text>
      </paragraph>
      <paragraph id="idCC761F628EBE494190F71A696093F14C">
        <enum>(9)</enum>
        <text>Better coordination is needed between Federal agencies—</text>
        <subparagraph id="id483D6BDDC84B4692BF69C7C60A7DB3D1">
          <enum>(A)</enum>
          <text>to align research strategies;</text>
        </subparagraph>
        <subparagraph id="idC69B7759DA994FE09872E3292C1BD6A2">
          <enum>(B)</enum>
          <text>to identify and address gaps in product development activity; and</text>
        </subparagraph>
        <subparagraph id="id8AAF3B0EE2A544A2AC395CB63B2DD54B">
          <enum>(C)</enum>
          <text>to move products efficiently along the research-to-introduction continuum.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="id8fae5c018e4147a38dcb1e93b96cbd40">
        <enum>(10)</enum>
        <text>Infectious diseases disproportionately impact populations in low-income nations across Latin
			 America, sub-Saharan Africa, and Asia. Poor and vulnerable communities in
			 the United States are also at risk for contracting diseases usually
			 considered to be diseases of the developing world. For example, cases of
			 Chagas disease, which is found throughout Latin America, and dengue fever,
			 endemic to Mexico and Central America, have been detected in communities
			 with high poverty rates in States along the United States border with
			 Mexico.</text>
      </paragraph>
      <paragraph id="id2f600a2ce5264fe2b2024db764390740">
        <enum>(11)</enum>
        <text>In collaboration with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="19UH" entity-type="federal-body">World Health Organization</cato:entity-ref> and its member states, the United States is a
			 leading participant in discussions to improve coordination and financing
			 of global health research and development. This process will establish
			 mechanisms to map research needs, identify resource gaps, and set
			 priorities to ensure that the most crucial global health products are
			 developed and delivered for maximum global health impact.</text>
      </paragraph>
      <paragraph id="id524c72c3bff1444393612e1ccbf59992">
        <enum>(12)</enum>
        <text>Because of its presence in the field, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> is uniquely placed—</text>
        <subparagraph id="id0297488569D346E2A1056ED45D354849">
          <enum>(A)</enum>
          <text>to assess local health conditions;</text>
        </subparagraph>
        <subparagraph id="id7594363C06C048D4B9DAE7D3340BE922">
          <enum>(B)</enum>
          <text>to partner with public and private stakeholders to ensure the development and timely introduction
			 and scale-up of tools that are culturally acceptable;</text>
        </subparagraph>
        <subparagraph id="idDAB4F83438F34A909A63099F7BE893FC">
          <enum>(C)</enum>
          <text>to address serious and all-too-common health problems; and</text>
        </subparagraph>
        <subparagraph id="id1C9A2D32CE744174B74F82D4A3ED1568">
          <enum>(D)</enum>
          <text>to contribute to the strengthening of health systems.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="idF03F73507051451393892097789D60D9">
        <enum>(13)</enum>
        <text>In a recent report to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> asserts that—</text>
        <subparagraph id="id27A264E7A20541D7A665A7CDA5AC5BFB">
          <enum>(A)</enum>
          <text>health research is <quote>integral</quote> to its <quote>ability to achieve its health and development objectives worldwide</quote>; and</text>
        </subparagraph>
        <subparagraph id="id5FC09A65FA9946DD9BE30BA3ED9A7C70">
          <enum>(B)</enum>
          <text>innovation through research allows the agency <quote>to develop and introduce affordable health products and practices and contribute to policies
			 appropriate for addressing health-related concerns in the developing world</quote>.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="idAFC1F6CC12164BF99F48E4238958BF14">
        <enum>(14)</enum>
        <subparagraph commented="no" display-inline="yes-display-inline" id="id8D01F8BC5B124CFDA23B3249BC25DD86">
          <enum>(A)</enum>
          <text>In <quote>Report to Congress: Health-Related Research and Development Activities at <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> (HRRD), May 2011</quote>, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> analyzed its activities from 2006 through 2010 and set forth a 5-year health research
			 strategy for the next 5 years.</text>
        </subparagraph>
        <subparagraph id="id4BE24FD3E5814952872625AA28831940" indent="up1">
          <enum>(B)</enum>
          <text>The new strategy is—</text>
          <clause id="id6E1C27CF888647438A1D68E1BCAE553B">
            <enum>(i)</enum>
            <text>an important source of information on <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>'s programs for global health product development; and</text>
          </clause>
          <clause id="id4833762F6FB14E2B9B509503ECCA3282">
            <enum>(ii)</enum>
            <text>an effective tool for measuring expected results from 2011 through 2015.</text>
          </clause>
        </subparagraph>
        <subparagraph id="id347043CBE9124D389D516CD38BF8EBD3" indent="up1">
          <enum>(C)</enum>
          <text>The strategy does not articulate <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>'s investments and programming for research and development
			 in several critical areas, including—</text>
          <clause id="idB6C300C5A0F94EABB92C4BAFF376DAA5">
            <enum>(i)</enum>
            <text>new tools to diagnose, prevent, and treat neglected tropical diseases;</text>
          </clause>
          <clause id="id08170B1BB0A648F7BD37D599E2D7946D">
            <enum>(ii)</enum>
            <text>research addressing the leading causes of death and illness of women, newborns, and children; and</text>
          </clause>
          <clause id="idDEC83ED6218844C190D30CF39D3A73A1">
            <enum>(iii)</enum>
            <text>new tuberculosis vaccines.</text>
          </clause>
        </subparagraph>
      </paragraph>
      <paragraph id="id52ac197c642b4aab8392074a65aeadeb">
        <enum>(15)</enum>
        <text>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> has established a variety of instruments to promote innovation and global health, such as—</text>
        <subparagraph id="id8AB84D0B9A9549D1A7C2F73BAE3C917A">
          <enum>(A)</enum>
          <text>Grand Challenges for Development;</text>
        </subparagraph>
        <subparagraph id="id4037A9C91F8E4F0DAA1C5AB71F0028C9">
          <enum>(B)</enum>
          <text>the Innovation Fund for the Americas;</text>
        </subparagraph>
        <subparagraph id="id4AF69536E8BA43DBB3A591A078AE4DA9">
          <enum>(C)</enum>
          <text>Higher Education Solutions Network (HESN);</text>
        </subparagraph>
        <subparagraph id="idAE702141CF6149A290E201A266FC46CE">
          <enum>(D)</enum>
          <text>university Development Labs; and</text>
        </subparagraph>
        <subparagraph id="idADE5E9B0BCB94F0EA84E2A9FF77E399C">
          <enum>(E)</enum>
          <text>Research and Innovation Fellowships.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="id1bae205730324081a26b921205928891">
        <enum>(16)</enum>
        <text>Research and development at <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>—</text>
        <subparagraph id="idcf60141443c64e228a39213a4854666a">
          <enum>(A)</enum>
          <text>facilitates public-private collaboration in the development of global health technologies;</text>
        </subparagraph>
        <subparagraph id="idf1ee66efe2d445d8b16efde8010973f0">
          <enum>(B)</enum>
          <text>leverages public and private sector support for early stage research and development of health
			 technologies to encourage private sector investment in late-stage
			 technology development and product introduction in developing countries;</text>
        </subparagraph>
        <subparagraph id="id76d78de8985343ad81d5277c17677a9c">
          <enum>(C)</enum>
          <text>benefits the United States economy by investing in the growing United States global health
			 technology sector, which—</text>
          <clause id="id603d7c8859714de88dabd7c82c73ddcc">
            <enum>(i)</enum>
            <text>provides skilled jobs for American workers (64 cents of every United States dollar invested in
			 global health research benefits United States-based researchers);</text>
          </clause>
          <clause id="id87ee6db1bbc84153aac73e517517f151">
            <enum>(ii)</enum>
            <text>creates opportunities for United States businesses in the development and production of new
			 technologies; and</text>
          </clause>
          <clause id="id9699781ee8e944f887e76efad711eed6">
            <enum>(iii)</enum>
            <text>enhances United States competitiveness in the increasingly technological and knowledge-based global
			 economy; and</text>
          </clause>
        </subparagraph>
        <subparagraph id="idf2ec18c5707149c3b9f923ac13d99073">
          <enum>(D)</enum>
          <text>enhances United States national security by—</text>
          <clause id="id0d68dd549d914548804152df61665eef">
            <enum>(i)</enum>
            <text>reducing the risk of pandemic disease; and</text>
          </clause>
          <clause id="idb1b5a21da4de4b02a322746be42ba660">
            <enum>(ii)</enum>
            <text>contributing to economic development and stability in developing countries.</text>
          </clause>
        </subparagraph>
      </paragraph>
      <paragraph id="id9d222eaf2a634c7b90d76ad107e704e9">
        <enum>(17)</enum>
        <text>The United States should invest in affordable, appropriate health technologies, including—</text>
        <subparagraph id="id13F2D0092A9941E3B00E35077CBDE7E1">
          <enum>(A)</enum>
          <text>medical devices for maternal, newborn, and child care;</text>
        </subparagraph>
        <subparagraph id="idE02755773BFB4AFF911138E3490EAD75">
          <enum>(B)</enum>
          <text>new vaccines;</text>
        </subparagraph>
        <subparagraph id="idFD925534A5F646908472D7FB3A861DEA">
          <enum>(C)</enum>
          <text>new vaccine technologies and delivery tools;</text>
        </subparagraph>
        <subparagraph id="idF9A4345055AD4F06824AA54F887D15E7">
          <enum>(D)</enum>
          <text>safe injection devices;</text>
        </subparagraph>
        <subparagraph id="id6B4C40BE0DCB43DD9F6FCCB68B519E4F">
          <enum>(E)</enum>
          <text>diagnostic tests for infectious diseases;</text>
        </subparagraph>
        <subparagraph id="idE477A7AC5E08478691FDA9B1AA4928B9">
          <enum>(F)</enum>
          <text>new tools for water, sanitation, and nutrition;</text>
        </subparagraph>
        <subparagraph id="idD41C9FE150954DA1B7323D9F09D84DC8">
          <enum>(G)</enum>
          <text>multipurpose prevention technologies;</text>
        </subparagraph>
        <subparagraph id="id59728FD7E2444270BA5878E59557796A">
          <enum>(H)</enum>
          <text>information systems and mobile health and information systems; and</text>
        </subparagraph>
        <subparagraph id="idEA72454BC8D84780B8564155D7CBD281">
          <enum>(I)</enum>
          <text>innovative disease prevention strategies.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="idE4C9EE5734D54D17A058404D491C89EF">
        <enum>(18)</enum>
        <text>United States investments in the health technologies set forth in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="21st Century Global Health Technology Act/s:2/p:17" proposed="true">paragraph (17)</cato:entity-ref> would—</text>
        <subparagraph id="id7705bea665254006ac92434493603925">
          <enum>(A)</enum>
          <text>reduce the risk of disease transmission;</text>
        </subparagraph>
        <subparagraph id="id022ef31cd7f4463aac007524c4e7c30f">
          <enum>(B)</enum>
          <text>accelerate access to life-saving global health interventions for the world's poor;</text>
        </subparagraph>
        <subparagraph id="id4fc6b340a1b047a8b0289fe83f1ffede">
          <enum>(C)</enum>
          <text>reduce the burden on local health systems; and</text>
        </subparagraph>
        <subparagraph id="id8ef56fad900a417faa5cea83a816dba3">
          <enum>(D)</enum>
          <text>result in significant cost savings for development assistance funds.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="id65a41057ef5b47ea932e1f8aceea7699">
        <enum>(19)</enum>
        <text>In circumstances where markets fail, public-private partnerships are an effective way to develop,
			 introduce and scale up new health technologies.</text>
      </paragraph>
      <paragraph id="id4EEDD61020414D0E93F516A665876648">
        <enum>(20)</enum>
        <subparagraph commented="no" display-inline="yes-display-inline" id="id6333A62E36AE4638A1F24CE878D5E2E7">
          <enum>(A)</enum>
          <text>Product development partnerships (referred to in this paragraph as <quote>PDPs</quote>) are a model of public-private partnership that is successfully accelerating research to benefit
			 the developing world.</text>
        </subparagraph>
        <subparagraph id="id05A29AD05B9E49469929F371AC31422D" indent="up1">
          <enum>(B)</enum>
          <text>PDPs are non-profit, nongovernmental entities that work to accelerate the development of new tools
			 to fight diseases in resource-poor settings.</text>
        </subparagraph>
        <subparagraph id="id0D4238B3963E44F2A6D9E16BEF7E9D83" indent="up1">
          <enum>(C)</enum>
          <text>PDPs typically manage resources and partnerships from across public, private, and philanthropic
			 sectors to drive the development of a full pipeline of potential new
			 products that could save and improve lives in the developing world.</text>
        </subparagraph>
        <subparagraph id="id349D535021944681AC4DED6B6CA29F80" indent="up1">
          <enum>(D)</enum>
          <text>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> has played a significant role in advancing the PDP model through its financial support.</text>
        </subparagraph>
        <subparagraph id="id9F4A0D22E0B949CC8CEE7F49D0897BE9" indent="up1">
          <enum>(E)</enum>
          <text>Between 2004 and 2013, the achievements of PDPs have become increasingly successful at advancing
			 new products through the development pipeline towards registration,
			 product introduction, and use.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="id7eef8b8f801742ce842d0d6a4a310983">
        <enum>(21)</enum>
        <text>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> supports research and introduction activities along a research-to-use continuum including—</text>
        <subparagraph id="id8d975c5705df40d881051743b21e09f4">
          <enum>(A)</enum>
          <text>evidence reviews and health assessments in developing countries; and</text>
        </subparagraph>
        <subparagraph id="iddd29a48ae8dc4e59af64e4aab03010b9">
          <enum>(B)</enum>
          <text>the development, testing, adaptation, and introduction of appropriate products and interventions
			 within the context of strengthening health systems.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="idd8b9c08391674e2583fdb409ee97cf1d">
        <enum>(22)</enum>
        <subparagraph commented="no" display-inline="yes-display-inline" id="idAB9D69847B1041909AB9D8375D2767D2">
          <enum>(A)</enum>
          <text>A Center for Accelerating Innovation and Impact (referred to in this paragraph as the <quote>Center</quote>) has been established at <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> to address technical, supply, and policy barriers in the
			 development, introduction, and scale-up of new products and technologies
			 for global health.</text>
        </subparagraph>
        <subparagraph id="id338917DE818344209D4F450F4153493B" indent="up1">
          <enum>(B)</enum>
          <text>For diseases and conditions in which market forces have proven insufficient to generate and rapidly
			 deliver new technologies, the Center promotes and reinforces solutions to
			 overcome obstacles such as regulatory inefficiencies in developing
			 countries, limited user demand, gaps in market data and supply chain
			 hurdles.</text>
        </subparagraph>
        <subparagraph id="id860A352888F34D5E8D9038FE06B9C637" indent="up1">
          <enum>(C)</enum>
          <text>The Center also catalyzes partnerships with the public and private sectors to develop and rapidly
			 deploy new products.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="idc60915ac267d4e42a3fb8957d1697b04">
        <enum>(23)</enum>
        <text>Since 1982, <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> has carried out a program to support the development of health technologies
			 through which <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>—</text>
        <subparagraph id="id138c044b96fe4de99948307630261f68">
          <enum>(A)</enum>
          <text>has maximized the limited resources available for global health;</text>
        </subparagraph>
        <subparagraph id="id1aff08d188524feab9ba3d927bc61e95">
          <enum>(B)</enum>
          <text>has ensured that products and medicines developed for use in low-resource settings have reached the
			 people that need such products and medicines;</text>
        </subparagraph>
        <subparagraph id="id36dbe627d2b34f46af8305c6be043c67">
          <enum>(C)</enum>
          <text>has invented, designed, developed, or co-developed 85 health technologies; and</text>
        </subparagraph>
        <subparagraph id="idF0759C1369444379AB472AD5623520F0">
          <enum>(D)</enum>
          <text>has collaborated with more than 100 private-sector organizations, which have matched the funds
			 received from <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> by a 2:1 ratio.</text>
        </subparagraph>
      </paragraph>
      <paragraph id="ide47ba1d4ac7640f7865bb30e3477495f">
        <enum>(24)</enum>
        <text>The research and development activities of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> are complementary to the work of other Federal
			 agencies.</text>
      </paragraph>
    </section>
    <section id="idfff210c7425a47caa5857f93d7a69ff9">
      <enum>3.</enum>
      <header>Purposes</header>
      <text display-inline="no-display-inline">The purposes of this Act are—</text>
      <paragraph id="id9A4D59FAF86444B49B102739AB10344A">
        <enum>(1)</enum>
        <text display-inline="yes-display-inline">to acknowledge the role of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">United States Agency for International Development</cato:entity-ref> (referred to in
			 this section as <quote>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>
          </quote>) in product development, introduction, and scale-up of new global health tools; and</text>
      </paragraph>
      <paragraph id="id4213171175BA4EA38F953BE1EEFAE5E3">
        <enum>(2)</enum>
        <text display-inline="yes-display-inline">to establish the Technologies for Health Program within <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> to support the development of
			 technologies
			 for global health that will—</text>
        <subparagraph id="id6f03a851be87481c9b077b9ee330e392">
          <enum>(A)</enum>
          <text>improve global health;</text>
        </subparagraph>
        <subparagraph id="id2944f6d24ede4bd4adcd193d3901766e">
          <enum>(B)</enum>
          <text>reduce maternal, newborn, and child mortality rates;</text>
        </subparagraph>
        <subparagraph id="id846a51b70177479e93ca8ad799693a19">
          <enum>(C)</enum>
          <text>improve health and nutrition;</text>
        </subparagraph>
        <subparagraph id="id32ee7f760c7c43c181f922dc645d04bd">
          <enum>(D)</enum>
          <text>reverse the incidence of HIV/AIDS, malaria, tuberculosis, and other infectious diseases;</text>
        </subparagraph>
        <subparagraph id="iddee3505798a4460a971135f8366d3664">
          <enum>(E)</enum>
          <text>reduce the burden of chronic diseases;</text>
        </subparagraph>
        <subparagraph id="id3788315981f249d19e2a52c28cd9498c">
          <enum>(F)</enum>
          <text>overcome technical, supply, and policy hurdles to product introduction and scale-up; and</text>
        </subparagraph>
        <subparagraph id="id231d6bb2a01441e3b79d7a667baa5110">
          <enum>(G)</enum>
          <text>support research and development that is consistent with a global development strategy and other
			 related strategies developed by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>.</text>
        </subparagraph>
      </paragraph>
    </section>
    <section id="idbf8427cbad154002b38146a5984f7383">
      <enum>4.</enum>
      <header>Establishment of Health Technologies Program</header>
      <subsection id="idD36D5BE151FF417391B4692A2C9244D3">
        <enum>(a)</enum>
        <header>In general</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Foreign Assistance Act of 1961/s:107">Section 107 of the Foreign Assistance Act of 1961</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/22/2151e">
            <cato:entity-ref entity-type="uscode" value="usc/22/2151e">22 U.S.C. 2151e</cato:entity-ref>
          </external-xref>)</cato:entity> is amended by adding at the end
			 the following:</text>
        <quoted-block display-inline="no-display-inline" id="id13496720820A46279B5C1295EBE9E1C6" style="OLC">
          <subsection id="id84D45419F2A247E8830020F6EC6055A9">
            <enum>(c)</enum>
            <header>Technologies for Health</header>
            <paragraph id="id854E197DE64F4889A331DAF67C3E26FE">
              <enum>(1)</enum>
              <header>Establishment</header>
              <text display-inline="yes-display-inline">There is established, within the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-parent-id="7200" value="Technologies for Health Program">Health and Infectious Diseases and Nutrition Section of the Global
			 Health Bureau of the United States Agency for International Development</cato:entity-ref>
			 (referred to in this
			 subsection as <quote>
                  <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>
                </quote>), the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-parent-id="7200" value="Technologies for Health Program">Technologies for Health Program</cato:entity-ref> (referred to in this subsection as the <quote>Program</quote>).</text>
            </paragraph>
            <paragraph id="id07107F30D26A41BDB35E5E328515FCFB">
              <enum>(2)</enum>
              <header>Functions</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Technologies for Health Program" entity-parent-id="7200">Program</cato:entity-ref> shall develop, advance, and introduce affordable, available, and appropriate and
			 primarily late-stage technologies specifically designed—</text>
              <subparagraph id="id70C9DCFDAFEA4893B3ED7DC99F92DE75">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">to improve the health and nutrition of populations in developing countries;</text>
              </subparagraph>
              <subparagraph id="idB5033FFDA7BA4B7BBBE494E20F75C050">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">to reduce maternal, newborn, and child mortality in such countries; and</text>
              </subparagraph>
              <subparagraph id="id03BB85A5A8DD48598F0B38A8ADDEAA35">
                <enum>(C)</enum>
                <text display-inline="yes-display-inline">to improve the diagnosis, prevention, and reduction of disease, especially HIV/AIDS, malaria,
			 tuberculosis, and other infectious diseases, in such countries.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="idD0407C4B0CF24AF38671891DA32FA718">
              <enum>(3)</enum>
              <header>Agreement</header>
              <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Technologies for Health Program" entity-parent-id="7200">Program</cato:entity-ref> shall be carried out under a cooperative agreement between <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> and 1 or more
			 institutions with a successful record of—</text>
              <subparagraph id="id397809B3A9E649B588BE9841A3E2DF65">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">advancing the technologies described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Foreign Assistance Act of 1961/s:107/ss:c/p:2" proposed="true">paragraph (2)</cato:entity-ref>; and</text>
              </subparagraph>
              <subparagraph id="id98CA5BC1EBAE4996AEECAE7D2551C52F">
                <enum>(B)</enum>
                <text display-inline="yes-display-inline">integrating practical field experience into the research and development process in order to
			 introduce the most appropriate technologies.</text>
              </subparagraph>
            </paragraph>
          </subsection>
          <subsection id="id4D49FD2C31D54F18BAAFFA2BD029CA6E">
            <enum>(d)</enum>
            <header>Action plans</header>
            <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">Administrator of USAID</cato:entity-ref> shall—</text>
            <paragraph id="idCCDEB9C450E348A6B97B55A78A93EF9F">
              <enum>(1)</enum>
              <text display-inline="yes-display-inline">establish and implement action plans to incorporate global health research and product development
			 within each of the global health and development programs, with support
			 from coordinating agencies;</text>
            </paragraph>
            <paragraph id="id94116CC5B7084BACBE1406FEA8614781">
              <enum>(2)</enum>
              <text display-inline="yes-display-inline">establish metrics to measure progress in implementing the action plans; and</text>
            </paragraph>
            <paragraph id="idA9B17D61E8A542A4A58566A68041C42F">
              <enum>(3)</enum>
              <text display-inline="yes-display-inline">consider all options in implementing the action plans, including the use of public-private
			 partnerships.</text>
            </paragraph>
          </subsection>
          <subsection id="idC569F69DB3384502B51D2CD6D59D106C">
            <enum>(e)</enum>
            <header>Priority global health interventions</header>
            <text display-inline="yes-display-inline">The 
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Center for Accelerating Innovation and Impact" entity-parent-id="7200">Center for Accelerating Innovation and Impact of USAID</cato:entity-ref>
               shall continue its work to speed the
			 development, introduction, and scale-up of priority global health
			 interventions.</text>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection>
      <subsection id="idAEB3521C22A342D08C96E3FD2AA468CC">
        <enum>(b)</enum>
        <header>Savings provision</header>
        <text display-inline="yes-display-inline">
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Foreign Assistance Act of 1961/s:107/ss:c" proposed="true">Section 107(c) of the Foreign Assistance Act of 1961</cato:entity-ref>, as added by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="21st Century Global Health Technology Act/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref>—</text>
        <paragraph id="id78C98AC6A8C241A1A4CFC96227E49ACD">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">authorizes the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">United States Agency for International Development</cato:entity-ref> (referred to in this subsection
			 and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="21st Century Global Health Technology Act/s:5" proposed="true">section 5</cato:entity-ref> as <quote>
              <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>
            </quote>) to continue the health
			 technologies research and development activities carried out by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>
			 before the date of the enactment of this Act; and</text>
        </paragraph>
        <paragraph id="idC7A0B77B9C7842229C2C952322A3FE65">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">does not establish a new program for such purposes.</text>
        </paragraph>
      </subsection>
    </section>
    <section id="idbe38e9756de1499ca313021867f856b2">
      <enum>5.</enum>
      <header>Annual report on research and development activities at USAID</header>
      <subsection id="id9a220d49dc234337a6955f1de5a8d945">
        <enum>(a)</enum>
        <header>In general</header>
        <text>Not later than 1 year after the date of the enactment of this Act, and annually thereafter for the
			 following 4 years, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">Administrator of the United States Agency for
			 International Development</cato:entity-ref>, after consultation with  the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7523" entity-type="federal-body">Centers for
			 Disease Control and Prevention</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="9700" entity-type="federal-body">Department of Defense</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and
			 Drug Administration</cato:entity-ref>, and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7529" entity-type="federal-body">National
			 Institutes of Health</cato:entity-ref>, shall submit a separate report to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> on
			 the research and
			 development activities carried out by
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>.</text>
      </subsection>
      <subsection id="id6261b1bb422944878fa01592f891f3a2">
        <enum>(b)</enum>
        <header>Matters To be included</header>
        <text>Each report submitted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="21st Century Global Health Technology Act/s:5/ss:a" proposed="true">subsection (a)</cato:entity-ref> shall include—</text>
        <paragraph id="id51377f6251244cb8bd69a8f752a42b9a">
          <enum>(1)</enum>
          <text>updates on the implementation of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>'s strategy for using research funds to stimulate the
			 development and introduction of products in each of its global health and
			 development programs;</text>
        </paragraph>
        <paragraph id="id21a9a4ac1e3b48b599f162059c40a1c1">
          <enum>(2)</enum>
          <text>a description of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>'s collaborations and coordination with other Federal departments and
			 agencies in support of translational and applied global health research
			 and development;</text>
        </paragraph>
        <paragraph id="idf1592415edbc4d4b93069e3c8749ffe5">
          <enum>(3)</enum>
          <text>a description of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>’s collaborations and coordination with partner governments, bilateral and
			 multilateral donors, and other relevant governmental entities in support
			 of translational and applied global health research and development;</text>
        </paragraph>
        <paragraph id="id996b4d4bb8584792b6658b4f3b28bb31">
          <enum>(4)</enum>
          <text>a description of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> investments in science, technology, and innovation;</text>
        </paragraph>
        <paragraph id="id3c7ae65df4f843368982df49ad442c10">
          <enum>(5)</enum>
          <text>an explanation of how technologies and research products developed by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref> complement work being
			 done by other Federal departments and agencies; and</text>
        </paragraph>
        <paragraph id="id9b5f85345c364b958c6ac5b3aeb0eee7">
          <enum>(6)</enum>
          <text>a list of technologies and research products that have been introduced into field trials or use.</text>
        </paragraph>
      </subsection>
      <subsection id="idc6246d9054684a80ac84d7d4dff321b6">
        <enum>(c)</enum>
        <header>Consultation</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">Administrator of USAID</cato:entity-ref> shall annually consult with the heads of other Federal departments and
			 agencies to improve alignment of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7200" entity-type="federal-body">USAID</cato:entity-ref>'s health-related research strategy
			 with other similar agency strategies, with the intent of working towards a
			 whole-of-government strategy for global health research and development.</text>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>